| Literature DB >> 29465611 |
Doris G Leung1,2, Julie S Cohen1, Elizabeth Harlan Michelle2, Renkui Bai3, Andrew L Mammen2,4,5, Lisa Christopher-Stine5.
Abstract
We report the cases of 2 patients who presented to our Myositis Center with myalgias and elevated creatine kinase levels. Muscle biopsy showed pathological features consistent with mitochondrial myopathy. In both cases, a single large deletion in mitochondrial DNA at low-level heteroplasmy was identified by next-generation sequencing in muscle tissue. In 1 case, the deletion was identified in muscle tissue but not blood. In both cases, the deletion was only identified on next-generation sequencing of muscle mitochondrial DNA and missed on array comparative genome hybridization testing. These cases demonstrate that next-generation sequencing of mitochondrial DNA in muscle tissue is the most sensitive method of molecular diagnosis for mitochondrial myopathy due to mitochondrial DNA deletions.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29465611 PMCID: PMC5824425 DOI: 10.1097/CND.0000000000000200
Source DB: PubMed Journal: J Clin Neuromuscul Dis ISSN: 1522-0443